{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:57:44Z","timestamp":1785315464938,"version":"3.55.0"},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6787","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T22:12:14Z","timestamp":1477951934000},"page":"3211-3214","source":"Crossref","is-referenced-by-count":6,"title":["Recurrent &lt;i&gt;Streptococcus agalactiae&lt;\/i&gt; Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-\u03b1 Inhibitor"],"prefix":"10.2169","volume":"55","author":[{"given":"Masataka","family":"Yoshida","sequence":"first","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"},{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"},{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Saijo","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Morinaga","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Imamura","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiga","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"},{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyomitsu","family":"Sawai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nagasaki Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(78)92274-2","volume":"2","author":"J Todd","year":"1978","unstructured":"1. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 2: 1116-1118, 1978.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hajjeh RA, Reingold A, Weil A, Shutt K, Schuchat A, Perkins BA. Toxic shock syndrome in the United States: surveillance update, 1979-1996. Emerg Infect Dis 5: 807-810, 1999.","DOI":"10.3201\/eid0506.990611"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 17: 251-272, 1990.","DOI":"10.3109\/10408419009105728"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 49: 85-92, 2009.","DOI":"10.1086\/599369"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 11: 569-576, 2005.","DOI":"10.1111\/j.1469-0691.2005.01169.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Andrews MM, Parent EM, Barry M, Parsonnet J. Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment. Clin Infect Dis 32: 1470-1479, 2001.","DOI":"10.1086\/320170"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Favalli EG, Desiati F, Atzeni F, et al. Serious infections during anti-TNF\u03b1 treatment in rheumatoid arthritis patients. Autoimmun Rev 8: 266-273, 2009.","DOI":"10.1016\/j.autrev.2008.11.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Schlievert PM, Gocke JE, Deringer JR. Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin Infect Dis 17: 26-31, 1993.","DOI":"10.1093\/clinids\/17.1.26"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10. Thomas S, Cunha BA. Group B streptococcal toxic shock-like syndrome with fulminant cellulitis. Heart Lung 25: 497-499, 1996.","DOI":"10.1016\/S0147-9563(96)80053-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Gardam MA, Low DE, Saginur R, Miller MA. Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. Arch Intern Med 158: 1704-1708, 1998.","DOI":"10.1001\/archinte.158.15.1704"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Holmstrom B, Grimsley EW. Necrotizing fasciitis and toxic shock-like syndrome caused by group B streptococcus. South Med J 93: 1096-1098, 2000.","DOI":"10.1097\/00007611-200011000-00011"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Tang WM, Ho PL, Yau WP, Wong JW, Yip DK. Report of 2 fatal cases of adult necrotizing fasciitis and toxic shock syndrome caused by <i>Streptococcus agalactiae<\/i>. Clin Infect Dis 31: E15-E17, 2000.","DOI":"10.1086\/318148"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Matsubara K, Mikamo H, Numa M, Yamamoto G, Kusano H, Takamine Y. Three fatal cases of invasive serotype VI group B streptococcal infection. J Infect 53: e139-e142, 2006.","DOI":"10.1016\/j.jinf.2005.11.023"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Chang B, Ikebe T, Wada A, et al. Surveillance of group B streptococcal toxic shock-like syndrome in nonpregnant adults and characterization of the strains in Japan. Jpn J Infect Dis 59: 182-185, 2006.","DOI":"10.7883\/yoken.JJID.2006.182"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Reich HL, Crawford GH, Pelle MT, James WD. Group B streptococcal toxic shock-like syndrome. Arch Dermatol 140: 163-166, 2004.","DOI":"10.1001\/archderm.140.2.163"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Sims KD, Barton TD. Group B streptococcal toxic shock syndrome in an asplenic patient: case report and literature review. Eur J Clin Microbiol Infect Dis 25: 208-210, 2006.","DOI":"10.1007\/s10096-006-0106-2"},{"key":"17","unstructured":"18. Begley JS, Barnes RC. Group B streptococcus toxic shock-like syndrome in a healthy woman: a case report. J Reprod Med 52: 323-325, 2007."},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Sendi P, Johansson L, Dahesh S, et al. Bacterial phenotype variants in group B streptococcal toxic shock syndrome. Emerg Infect Dis 15: 223-232, 2009.","DOI":"10.3201\/eid1502.080990"},{"key":"19","unstructured":"20. Chihara D, Sakamoto T, Murakami G, Takeoka T, Ohno T. An overwhelming post-splenectomy infection with toxic shock syndrome by group B <i>Streptococcus<\/i>. Rinsho Ketsueki (Jpn J Clin Hematol) 51: 253-257, 2010 (in Japanese, Abstract in English)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Al Akhrass F, Abdallah L, Berger S, et al. <i>Streptococcus agalactiae<\/i> toxic shock-like syndrome: two case reports and review of the literature. Medicine (Baltimore) 92: 10-14, 2013.","DOI":"10.1097\/MD.0b013e31827dea11"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Ikebe T, Chiba K, Shima T, et al. Evaluation of streptococcal toxic shock-like syndrome caused by group B streptococcus in adults in Japan between 2009 and 2013. J Infect Chemother 21: 207-211, 2015.","DOI":"10.1016\/j.jiac.2014.12.002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Descloux E, Perpoint T, Ferry T, et al. One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis 27: 37-43, 2008.","DOI":"10.1007\/s10096-007-0405-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Lachenauer CS, Kasper DL, Shimada J, et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 179: 1030-1033, 1999.","DOI":"10.1086\/314666"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Balci DD, Duran N, Ozer B, Gunesacar R, Onlen Y, Yenin JZ. High prevalence of <i>Staphylococcus aureus<\/i> cultivation and superantigen production in patients with psoriasis. Eur J Dermatol 19: 238-242, 2009.","DOI":"10.1684\/ejd.2009.0663"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Zhang K, Li X, Yin G, Liu Y, Niu X, Hou R. Functional characterization of CD4<sup>+<\/sup>CD25<sup>+<\/sup> regulatory T cells differentiated <i>in vitro<\/i> from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder. Br J Dermatol 158: 298-305, 2008.","DOI":"10.1111\/j.1365-2133.2007.08359.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Koike T, Harigai M, Inokuma S, et al. Postmarketing surveillance of the safety and effectiveness of etanercept in Japan. J Rheumatol 36: 898-906, 2009.","DOI":"10.3899\/jrheum.080791"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Tobin AM, Kirby B. TNF\u03b1 inhibitors in the treatment of psoriasis and psoriatic arthritis. BioDrugs 19: 47-57, 2005.","DOI":"10.2165\/00063030-200519010-00006"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Uthman I, Husari A, Touma Z, Kanj SS. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept. Rheumatology 44: 1200-1201, 2005.","DOI":"10.1093\/rheumatology\/keh680"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. Lovell DJ, Giannini EH, Reiff A, et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 48: 218-226, 2003.","DOI":"10.1002\/art.10710"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31. Renaud C, Ovetchkine P, Bortolozzi P, Saint-Cyr C, Tapiero B. Fatal group A <i>Streptococcus<\/i> purpura fulminans in a child receiving TNF-\u03b1 blocker. Eur J Pediatr 170: 657-660, 2011.","DOI":"10.1007\/s00431-010-1341-1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32. Weinblatt ME, Abbott GF, Koreishi AF. Case records of the Massachusetts General Hospital. N Engl J Med 360: 1770-1779, 2009.","DOI":"10.1056\/NEJMcpc0809066"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/21\/55_55.6787\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T08:23:18Z","timestamp":1718871798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/21\/55_55.6787\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":31,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6787","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}